5093-81-2

Upstream product

• 5353-90-2 8-methyl-2-phenylquinoline 
• 90034-64-3 2-phenyl-4(1H)-quinolone-8-carboxylic acid 
• 107027-34-9 2-phenyl-8-methylquinoline-4-carboxylic acid 
• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 100-52-7 benzaldehyde 
• 134-20-3 2-carbomethoxyaniline 
• 107027-76-9 8-(methoxycarbonyl)-2-phenyl-4(1H)-quinolone 
• 95-53-4 o-toluidine 
• 91-63-4 2-methylquinoline 
• 14371-10-9 (E)-3-phenylpropenal 
• 118-92-3 anthranilic acid 
• 117874-60-9 2-[2-Ethoxycarbonyl-1-phenyl-eth-(E)-ylideneamino]-benzoic acid methyl ester 

Downstream Products

• 117874-41-6 2-Phenyl-quinoline-8-carboxylic acid (2-morpholin-4-yl-ethyl)-amide; hydrochloride 
• 107026-86-8 N-<(2-dimethylamino)ethyl>-2-phenylquinoline-8-carboxamide dihydrochloride 
• 116529-78-3 2-phenylquinolin-8-ylamine 
• 1301759-14-7 8-(1H-benzimidazol-2-yl)-2-phenylquinoline 
• 1312339-03-9 2-phenyl-8-(1-isopropylbenzimidazol-2-yl)quinoline 
• 1312339-02-8 2-phenyl-8-(1-ethylbenzimidazol-2-yl)quinoline 
• 1301759-16-9 2-phenyl-8-(1-methylbenzimidazol-2-yl)quinoline 
• 107027-08-7 2-(4-Methanesulfonylamino-phenyl)-quinoline-8-carboxylic acid (2-dimethylamino-ethyl)-amide; hydrochloride 
• 107027-05-4 2-(4-Nitro-phenyl)-quinoline-8-carboxylic acid (2-dimethylamino-ethyl)-amide; hydrochloride 
• 107027-07-6 2-(4-Acetylamino-phenyl)-quinoline-8-carboxylic acid (2-dimethylamino-ethyl)-amide; hydrochloride 
• 107027-06-5 N-<2-(dimethylamino)ethyl>-2-(4-aminophenyl)quinoline-8-carboxamide dihydrochloride 
• 412043-30-2 N-1-{[2-(N'-tert-butoxycarbonyl-N'-{[2-(N-tert-butoxycarbonyl-N-{[2-(2-phenylquinoline-8-carbonyl)amino]ethyl})amino]ethyl})amino]ethyl}-9-methylphenazine-1-carboxamide 
• 107027-77-0 2-(4-Nitrophenyl)quinoline-8-carboxylic acid 
• 107026-89-1 2-Phenyl-quinoline-8-carboxylic acid (5-dimethylamino-pentyl)-amide; hydrochloride 

Relevant academic research and scientific papers

Substituted quinoline derivatives and pharmaceutical compositions thereof

The novel class of substituted quinolines represented by the general formula (I): STR1 where each of R1 and R2 separately represents H or up to three of the groups lower alkyl, halogen, CF3, CN, SO2 CH3, NO2, OH, NH2, NHSO2 R3, NHCOOR3, OR3, SR3, NHR3 or NR3 R3 (where R3 is lower alkyl optionally substituted with hydroxy, amino or ether functions), and each of R1 and R2 may additionally separately represent the substitution of an aza (--N=) group for one or two of the methine (--CH=) groups in each of the carbocyclic rings, and R1 may also represent, at positions 2', 3' or 4' only, a phenyl ring optionally further substituted with lower alkyl, halogen, CF3, CN, SO2 CH3, NO2, OH, NH2, NHCOR3, NHCOOR3, OR3, SR3, NHR3 or NR3 R3 (where R3 is lower alkyl optionally substituted with hydroxy, amino or ether functions); Y represents C(NH)NH2, NHC(NH)NH2 or NR4 R5, where each of R4 and R5 is H or lower alkyl optionally substituted with hydroxy, amino or ether functions, or R4 and R5 together with the nitrogen atom form a heterocyclic ring; and n is from 2 to 6; and the acid addition salts and 1-N-oxides thereof, possess antibacterial and antitumor properties.

Potential antitumor agents. 57. 2-Phenylquinoline-8-carboxamides as 'minimal' DNA-intercalating antitumor agents with in vivo solid tumor activity

A series of phenyl-substituted derivatives of the 'minimal' DNA-intercalating agent N-[2-(dimethylamino)-ethyl]-2-phenylquinoline-8-carboxamide (1) have been synthesized and evaluated for in vivo antitumor activity, in a continuing search for active compo

Potential Antitumor Agents. 56. "Minimal" DNA-Intercalating Ligands as Antitumor Drugs: Phenylquinoline-8-carboxamides

A series of isomeric phenylquinoline-8-carboxamides have been synthesized and evaluated as antitumor agents.This configuration is close to the minimum chromophore required for intercalative binding, since the binding mode of the compounds is dependent on